Cargando…

Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Pesenacker, AM, Zavitsanou, Stavroula, Nistala, Kiran, Wedderburn, Lucy R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194403/ https://www.ncbi.nlm.nih.gov/pubmed/22152334 http://dx.doi.org/10.1186/1546-0096-9-S1-O1

Ejemplares similares

Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile
por: Pesenacker, AM, et al.
Publicado: (2011)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
por: Hunter, PJ, et al.
Publicado: (2008)

PReS-FINAL-1002: Dissecting the dissociation of foxp3 and cd25 expression on cd4+ t cells in synovial fluid identifies three distinct subpopulations of human t regulatory cells present at the chronically inflamed site
por: Bending, D, et al.
Publicado: (2013)

Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis
por: Omoyinmi, Ebun, et al.
Publicado: (2012)

PReS-FINAL-2069: T cells secreting granulocyte-macrophage colony stimulating factor (GM-CSF) within the inflammed joint originate from an "EX-Th17" population
por: Nistala, K, et al.
Publicado: (2013)

PReS-FINAL-1001: Lymphocytes from the inflamed joint of juvenile idiopathic arthritis patients express reduced levels of cd73 and have a functional defect in adenosine production
por: Botta Gordon-Smith, S, et al.
Publicado: (2013)

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
por: Hinze, CH, et al.
Publicado: (2008)

Update in juvenile myositis
por: Nistala, Kiran, et al.
Publicado: (2013)

T Cell Expression of Granulocyte–Macrophage Colony-Stimulating Factor in Juvenile Arthritis Is Contingent Upon Th17 Plasticity
por: Piper, Christopher, et al.
Publicado: (2014)

The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource
por: Lawson-Tovey, Saskia, et al.
Publicado: (2023)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
por: Yokota, S, et al.
Publicado: (2008)

CD4(+)FOXP3(+) regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
por: Vercoulen, Yvonne, et al.
Publicado: (2011)

OA30 Genetic analysis of whole exome sequencing in a cohort of children with refractory JIA reveals genetic risk factors for rare juvenile diseases
por: Tordoff, Melissa, et al.
Publicado: (2022)

Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA)
por: Hansmann, Sandra, et al.
Publicado: (2015)

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
por: Livermore, P, et al.
Publicado: (2008)

Association of the IL-10 Gene Family Locus on Chromosome 1 with Juvenile Idiopathic Arthritis (JIA)
por: Omoyinmi, Ebun, et al.
Publicado: (2012)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
por: De Benedetti, Fabrizio, et al.
Publicado: (2012)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

YIM-O13. Development of novel protein biomarkers for the prediction of response to treatment in juvenile idiopathic arthritis
por: Palman, Jason, et al.
Publicado: (2014)

Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression
por: Hunter, Patricia J, et al.
Publicado: (2010)

Juvenile idiopathic arthritis (JIA) and early diagnosis of temporo-mandibular joint (TMJ) disorders
por: Alpigiani, MG, et al.
Publicado: (2008)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
por: Zak, M, et al.
Publicado: (2008)

Talus Arthritis Pattern in Juvenile Idiopathic Arthritis (JIA)
por: Alkhreisat, Mohammad, et al.
Publicado: (2019)

Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
por: Moncrieffe, H, et al.
Publicado: (2011)

PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA)
por: Aikawa, N, et al.
Publicado: (2013)

Ultrasound guided joint fluid aspiration and corticosteroid injection in patients with juvenile idiopathic arthritis (JIA)
por: Heuck, C, et al.
Publicado: (2008)

7.2 Interleukin-17 (IL-17) secreting cells in synovial fluid express the "Th17" master transcription factor RORC and their numbers correlate with CCL20 levels within the joint
por: Nistala, K, et al.
Publicado: (2008)

OA31 Successes and challenges in harmonising 4 national Juvenile Idiopathic Arthritis cohorts: an example from CLUSTER consortium
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH
por: De Benedetti, F, et al.
Publicado: (2013)

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
por: Ursu, S, et al.
Publicado: (2011)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
por: Alpigiani, MG, et al.
Publicado: (2008)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
por: Officioso, A, et al.
Publicado: (2011)

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
por: Nørgaard, M, et al.
Publicado: (2011)

Pregnancy outcomes in women affected by juvenile idiopathic arthritis (JIA)
por: Alpigiani, Maria Giannina, et al.
Publicado: (2014)

Treatment prescribing patterns in a cohort of patients with juvenile idiopathic arthritis (JIA). Data from the childhood arthritis prospective study (CAPS)
por: Davies, Rebecca, et al.
Publicado: (2014)

Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS)()()
por: Davies, Rebecca, et al.
Publicado: (2016)

Medication therapy patients with juvenile idiopathic arthritis (JIA), who needed joint replacement in adult life
por: Shelepina, Tatiana A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d45ftij9s1obarq3je6b05mqd1